Navigation Links
Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results
Date:3/10/2008

REDWOOD SHORES, Calif., March 10 /PRNewswire-FirstCall/ -- (OTC Bulletin Board: CICI) -- Communication Intelligence Corporation ("CIC" or the "Company"), a leading supplier of electronic signature solutions for the financial industry and the recognized leader in biometric signature verification, announced today its financial results for the fourth quarter and the year ended December 31, 2007.

Revenue for the three months ended December 31, 2007 increased 63% to $800,000, compared to $492,000 for the corresponding prior year period. The Company reported a net loss of $644,000, or $0.01 per share on 129 million weighted average shares outstanding for the fourth quarter ending December 31, 2007, compared to a net loss of $881,000, or $0.01, on 107 million weighted average shares outstanding for the corresponding prior year period. The decrease in net loss is primarily due to an increase in revenue during the fourth quarter of 2007 compared to the corresponding period in 2006.

Revenue for the year ended December 31, 2007 was $2,145,000 compared to $2,342,000 for the year ended December 31, 2006. The decrease in revenues is primarily due to a decrease in maintenance revenues compared to the prior year period. Revenue for 2007 was primarily attributable to Access Systems of Americas, Inc. (formerly PalmSource, Inc.), Advanced Computer Technology, AEGON/World Financial Group, AIG/AGLA, Bank of America, Charles Schwab & Co., eCom Asia Pacific, Fidelity National Info Services/LSI, Fiserv/IntergraSys, IA Systems, Misys Healthcare Systems, Oracle Corporation, Prudential Financial Inc., Snap-on Credit LLC, Sony Ericsson Corp., Tennessee Valley Authority, and Wells Fargo Bank NA.

The net loss for the twelve months ended December 31, 2007 was $3,399,000, or $0.03 per share, on 114 million weighted shares outstanding compared to a net loss of $3,286,000 or $0.03 per share on 107 million weighted average shares outstanding for the corresponding prior yea
'/>"/>

SOURCE Communication Intelligence Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology news :

1. Scripps research team blocks bacterial communication system to prevent deadly staph infections
2. 2 French scientists win European award for communication
3. Springer book wins Quality of Communication Award
4. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
5. A private bandwidth for communication in bats: Evidence from insular horseshoe bats
6. M2SYS Introduces Revolutionary Biometric Artificial Intelligence Technology to Significantly Reduce Fingerprint Software False Reject Rates
7. Humans and monkeys share Machiavellian intelligence
8. Genetic contributions to human brain morphology and intelligence
9. Director of National Intelligence to Speak at Conference
10. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
11. Director of National Intelligence to Speak at Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ADELPHIA Assurance of a cancer-free status did no...terized tomography (CT) lung-cancer screening prog... wrote in a study published in Cancer Epidemiolog...ican Association for Cancer Research. The December...ese findings should negate widespread concern in t...
(Date:12/2/2009)...KEN - A team comprised of undergraduate students f...p honors in a national poster contest hosted by th...ring (ISPE). , The annual contest highlights the...ast month at the ISPE Annual Meeting in San Diego,... of a Posterior Criciate Ligament Tensioning Devic...
(Date:12/2/2009)...Manpei Suzuki Diabetes Foundation is pleased to an... Donald F. Steiner, MD, A. N. Pritzker Distinguish...cine and Biochemistry and Molecular Biology, The U...gurated in 2008 to commemorate the 15th anniversar...ng those who have enlightened researchers in the f...
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2New IVF Guidelines Aim to Reduce Multiple Births 59861 1New IVF Guidelines Aim to Reduce Multiple Births 59861 2Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 1Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 2Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 3Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 4Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 5Paging All Science and Medical Mavens 3A Get To Philadelphia Stat for Body Worlds and Beyond 59857 1Paging All Science and Medical Mavens 3A Get To Philadelphia Stat for Body Worlds and Beyond 59857 2Paging All Science and Medical Mavens 3A Get To Philadelphia Stat for Body Worlds and Beyond 59857 3Paging All Science and Medical Mavens 3A Get To Philadelphia Stat for Body Worlds and Beyond 59857 4
... Today, the International Society for Stem Cell R...organization of stem cell researchers, released ne...fe and effective stem cell therapies for patients....es for the Clinical Translation of Stem Cells will...of Cell Stem Cell , the official affiliated journ...
...romises to enable cheap, lifesaving new drugs to t...laria, and to create innovative biofuels that can ...cience and its applications are raising questions:... scientists purposely changing the definition of w...intentionally equipping terrorists with frightenin...
...king for a mate? Move! Tracking and remote sensing... find out what they are up to. However, general th...re on Movement Ecology in the journal Proceedings... present integrative models for movement of organi...marine larvae and cheetahs. , "Our goal is to deve...
Other Biology News:The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Synthetic biology: Is ethics a showstopper? 2New movement models tested at the Smithsonian in Panama 2
(Date:12/2/2009)...Newswire/ -- S*BIO Pte Ltd today announced data pr...18, at The American Society of Hematology 51st Ann...ata will be presented on the clinical results from...ling its safety, tolerability and pharmacokinetic/...ging from 100 to 600 mg. These doses were administ...
(Date:12/2/2009)...Newswire-Asia/ -- The world is going through,extra...inty is part of many,businesses and industries. It...ively immune to the economic downturn, because ill...e midst of the difficult times this year, the phar... an R&D center in Shanghai, the largest of,its...
(Date:12/1/2009)...1 PDL BioPharma, Inc. (P...nce for the fourth quarter ended December 31, 2009...9 million for the fourth quarter of 2008. Included...wo installment payments of $12.5 million from Alex... was a one-time $1.8 million payment from Genentec...
(Date:12/1/2009)...Newswire/ -- Harvest Technologies Corp. ( www.harv...pany sponsored 60-patient clinical trial conducted...ia using the company,s BMAC System to treat patien... (CLI). Sri Ramachandra Medical Center is a Harvar...ed in Chennai, India and one of the largest privat...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
... United States Council for,Automotive Research LLC...or,Company and General Motors Corporation, welcome... FreedomCAR and Fuel Partnership, as announced by,...) at the Automotive Hall,of Fame in Dearborn, Mich... named as new members of,the Partnership by U.S. D...
...FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics"...owing U.S.,Food and Drug Administration (FDA) revi...cal trial using intravenous administration of REOL...atin in patients with advanced head,and neck cance...of the,Cancer Therapy and Research Center, Univers...
...searchers at Purdue University are developing a mi...nside laptops and personal computers, a cooling te...ing the size of computers. , Unlike conventional ...through finned devices called heat sinks attached ...ramatically increase how much heat could be remove...
Other Biology Technology:U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 2U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 3U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 4Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3Tiny refrigerator taking shape to cool future computers 2Tiny refrigerator taking shape to cool future computers 3
Rabbit Anti-Human PITPNB Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Human MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Sheep Anti-Streptomycin Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Biology Products: